A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-clair SPHP700-3 in the management of mild to moderate dry eye in adults

Cornea

Volumn 30, Issue 3, 2011, Pages 265-268

  Villani, Edoardo ^a   Laganovska, Guna ^b   Viola, Francesco ^a   Pirondini, Cesare ^a   Baumane, Kristine ^b   Radecka, Liga ^b   Ratiglia, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

dry eye; ocular surface; over the counter eyedrops; preservative free formulation

Indexed keywords

ARTIFICIAL TEAR; PLACEBO; SPHP 7003; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY EYE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; SYMPTOM; TEAR FILM; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRY EYE SYNDROMES; FLUOROPHOTOMETRY; HUMANS; LISSAMINE GREEN DYES; NONPRESCRIPTION DRUGS; OPHTHALMIC SOLUTIONS; PLANT EXTRACTS; POVIDONE; PRESERVATIVES, PHARMACEUTICAL; QUESTIONNAIRES; TEARS; TREATMENT OUTCOME;

EID: 79951774769     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181e9aab8     Document Type: Article

References (10)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:75-92.
2. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome. A Delphi approach to treatment recommendations. Cornea. 2006;25:90-97.
3. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:163-178.
4. Fedeniuk RW, Biliaderis CG. Composition and physicochemical properties of linseed (Linum usitatissimum L.) mucilage. JAgric Food Chem. 1994;42:240-247.
5. Malet F, Karsenti D, Pouliquen P. Preservative-free ocular hydrating agents in symptomatic contact lens wearers: saline versus PVP solution. Eye Contact Lens. 2003;29:38-43. (Pubitemid 43196996)
6. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:93-107.
7. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000; 118:615-21. (Pubitemid 30327337)
8. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:108-152.
9. Walt J. Ocular Surface Disease Index (OSDI) Administration and Scoring Manual. Irvine, CA: Allergan, Inc; 2004.
10. Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010; 128:94-101